Industry News
Biotechnology Industry News
A COVID-19 vaccine delivered with a patch rivals traditional shots in mice: study
A COVID-19 vaccine delivered with a patch rivals traditional shots in mice: study klahucik Thu, 10/28/2021 - 12:28
Telecom tycoon’s phase 3 pancreatic cancer bet flames out, sending stock to the basement
Telecom tycoon's phase 3 pancreatic cancer bet flames out, sending stock to the basement ntaylor Thu, 10/28/2021 - 08:05
Sanofi hit by filing delays for key drugs, drops an early Sangamo thalassemia asset
Sanofi hit by filing delays for key drugs, drops an early Sangamo thalassemia asset badams Thu, 10/28/2021 - 05:12
How targeting a genetic signature of cellular stress may boost cancer immunotherapy
How targeting a genetic signature of cellular stress may boost cancer immunotherapy aliu Wed, 10/27/2021 - 12:51
Frazier has raised an $830M public life science fund. Here’s how it plans to invest the cash
Frazier has raised an $830M public life science fund. Here's how it plans to invest the cash ntaylor Wed, 10/27/2021 - 10:48
Duke and UC scientists find a potential remedy for chronic pain from a ‘junkyard of cancer drugs’
Duke and UC scientists find a potential remedy for chronic pain from a 'junkyard of cancer drugs' arlene.weintraub Wed, 10/27/2021 - 10:00
GSK, after pushing past midphase fail, ends development of otilimab in COVID-19
GSK, after pushing past midphase fail, ends development of otilimab in COVID-19 ntaylor Wed, 10/27/2021 - 08:58
ElevateBio cuts a deal for Life Edit, adding genome engineering tech to support gene therapy pipeline
ElevateBio cuts a deal for Life Edit, adding genome engineering tech to support gene therapy pipeline ntaylor Wed, 10/27/2021 - 07:57
After COVID flop, Angion’s leading med fails again, this time in kidney transplant patients as shares halved
After COVID flop, Angion's leading med fails again, this time in kidney transplant patients as shares halved badams Wed, 10/27/2021 - 04:48
Inclusion of women in stroke trials hasn’t changed in 30 years: study
Inclusion of women in stroke trials hasn't changed in 30 years: study klahucik Tue, 10/26/2021 - 11:15
Lilly, Pfizer stop development of osteoarthritis drug after FDA rejection, extending bleak run for NGF inhibitors
Lilly, Pfizer stop development of osteoarthritis drug after FDA rejection, extending bleak run for NGF inhibitors ntaylor Tue, 10/26/2021 - 08:00
Novartis dumps Rett gene therapy caught up in Zolgensma scandal in cull of pipeline prospects
Novartis dumps Rett gene therapy caught up in Zolgensma scandal in cull of pipeline prospects ntaylor Tue, 10/26/2021 - 07:20
UPDATE: Eli Lilly kick-starts speedy FDA review for Alzheimer’s hopeful donanemab—and a one-on-one test against Aduhelm
UPDATE: Eli Lilly kick-starts speedy FDA review for Alzheimer's hopeful donanemab—and a one-on-one test against Aduhelm badams Tue, 10/26/2021 - 06:59
Intellia, LogicBio fuel hope for in vivo gene editing with new animal data in rare diseases: report
Intellia, LogicBio fuel hope for in vivo gene editing with new animal data in rare diseases: report arlene.weintraub Mon, 10/25/2021 - 10:53
Juventas Cell Therapy closes a $63M funding round as it eyes a big push for blood cancer hopeful
Juventas Cell Therapy closes a $63M funding round as it eyes a big push for blood cancer hopeful badams Mon, 10/25/2021 - 08:59
AstraZeneca veteran takes up CEO post at Medivir, becoming 4th person to hold the post in quick succession
AstraZeneca veteran takes up CEO post at Medivir, becoming 4th person to hold the post in quick succession ntaylor Mon, 10/25/2021 - 08:26
EMA starts rolling review of Merck’s molnupiravir, continuing rapid regulatory response to COVID-19 antiviral data
EMA starts rolling review of Merck's molnupiravir, continuing rapid regulatory response to COVID-19 antiviral data ntaylor Mon, 10/25/2021 - 07:41
Egle Therapeutics nabs $46M as it looks to push into the clinic with next-gen Tregs platform
Egle Therapeutics nabs $46M as it looks to push into the clinic with next-gen Tregs platform badams Fri, 10/22/2021 - 07:28
Metacrine shares halved as NASH program nixed on mixed bag data and early safety issue
Metacrine shares halved as NASH program nixed on mixed bag data and early safety issue badams Fri, 10/22/2021 - 06:32
Could cancer drugs address a hard-to-treat lung disease? Researchers say 2 look promising
Could cancer drugs address a hard-to-treat lung disease? Researchers say 2 look promising klahucik Thu, 10/21/2021 - 17:51